HBA Metro - Patient Advocacy – Real Trust, Real Partnerships for Real Innovation

Summary: 

This well-attended Executive Women’s Breakfast (EWB) featured an executive panel discussing “Patient Advocacy – Real Trust, Real Partnerships for Real Innovation.” The moderated panel discussion featured an audience response system (ARS) to engage and capture the responses of the attendees.

This well-attended Executive Women’s Breakfast (EWB) featured an executive panel discussing “Patient Advocacy – Real Trust, Real Partnerships for Real Innovation.” The moderated panel discussion featured an audience response system (ARS) to engage and capture the responses of the attendees.

Panelists included:

  • Moderator: Wendy Lund, CEO, GCI Health
  • Ellen Lambert, executive director, corporate contributions and EVP, The Merck Company Foundation
  • Anne Quinn Young, VP communications, Multiple Myeloma Research Foundation
  • Ann Moravick, CEO and founder, Rx 4 Good
  • Caleb DesRosiers, VP and COO, HillCo Health

During the ARS “warm up” session, the audience was asked what type of company they worked for. The ARS response indicated that 68.9% of attendees worked for a pharmaceutical company, 0% for biotech, 24.4% for an agency or service provider and 6.7% for a nonprofit organization. Audience members were also asked if they had previously attended an EWB program. The ARS response showed that 40% of the attendees were at their first EWB event.

View the report which summarizes the topics, ARS results and the panel discussions by topics.PDF icon

Charlotte McKines, vice president, Merck welcomed the group
Charlotte McKines, vice president, Merck welcomed the group

A spirited panel discussion
A spirited panel discussion focused on the changes to the industry and patient advocacy programs

The EWB organizers and panel members
The EWB organizers and panel members

News Categories: 
Groups audience: